VNRX — VOLITIONRX LTD
—
NYSE ·
Health Care ·
Life Sciences Tools & Services ·
CIK 93314 ·
Last close
$0.25
Market Cap
$4.78M
52W High
$14.80
52W Low
$0.23
ADV30
16,825,358
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 398,657 | — | -4,201,897 | -7,326,047 | 8,300,986 | 2,790,994 | 41,840,346 |
| Mar 2026 | 985,076 | — | -5,228,321 | -6,664,774 | 9,036,483 | 3,102,817 | 42,396,412 |
| Dec 2025 | 447,034 | — | -4,731,280 | -6,270,832 | 6,901,227 | 1,117,028 | 42,494,038 |
| Sep 2025 | 627,277 | — | -4,868,806 | -5,378,358 | 6,448,885 | 199,407 | 42,398,447 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,665,448
Investing CF
$-96,964
Financing CF
$21,041,954
CapEx
$-98,772
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-4.29
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-259,566,144
Inventory
—
Receivables
$252,242
ST Investments
—
EBIT TTM
$-21,761,613
Pretax Income TTM
$-24,730,259
Interest Exp TTM
$2,968,646
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,458,044
EBITDA
$-18,572,584
Free Cash Flow
$-9,213,488
Enterprise Value
$11,478,928
Total Cash
$2,790,994
Total Debt
$11,410,300
Shares Out
18,901,109
Trailing EPS
$-3.85
Book Value
$-2.67
ROE
—
ROA
-142.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,727,384 | -21,222,056 | -23,357,027 | 6,901,227 | 42,494,038 | -34,246,393 | -19,683,334 |
| Dec 2024 | 1,233,511 | -26,921,602 | -26,967,836 | 9,399,523 | 35,507,259 | -24,907,620 | -25,893,624 |
| Dec 2023 | 775,302 | -35,773,244 | -35,319,078 | 27,950,498 | 36,662,720 | -7,802,255 | -18,062,999 |
| Dec 2022 | 306,392 | -30,550,647 | -30,268,793 | 18,295,054 | 21,422,016 | -2,574,991 | -15,277,742 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.85
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | $4.45M | $7.41 | — |
| TRIB | TRINITY BIOTECH PLC | $5.46M | $6.72 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.60M | $1.89 | — |
| BUDZ | WEED, INC. | $3.68M | $0.02 | — |
| QCLS | Q/C TECHNOLOGIES, INC. | $6.82M | $0.83 | — |
News headlines (Yahoo Finance, 1h cache)
VolitionRx Participates in Launch of DETECSEPS Program in France
2026-09-17 12:17 · Yahoo
VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Co
2026-09-14 16:17 · Yahoo
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
2026-09-14 12:17 · Yahoo
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
2026-08-27 11:35 · Yahoo
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
2026-08-26 13:17 · Yahoo
Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis
2026-08-26 12:17 · Yahoo
Volition (VNRX) Q2 2026 Earnings Call Transcript
2026-08-20 23:28 · Yahoo
Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology
2026-08-05 12:17 · Yahoo
Volition Advances Nu.Q® NETs Platform Towards Commercialization
2026-07-30 12:17 · Yahoo
VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
2026-07-07 12:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.